About Customers Ideas Log in Book an RFP walkthrough
The Commercial Intelligence Platform for mid-cap CROs

Win more of the studies you bid for.

Yendou gives CRO commercial and delivery teams the intelligence and capacity to pursue more opportunities, build stronger bids, and win more sponsor business.

Book an RFP walkthrough See customer outcomes
Commercial impact

Compete for more. Prove more. Win more.

Give commercial teams the capacity to pursue more qualified opportunities and the intelligence to build stronger, evidence-backed bids.

Then let the metrics do the talking.

The bid window

Winning the study takes more than writing the proposal.

CROs have ten days to build a project delivery strategy and prove it. But gathering data, chasing SMEs, and waiting on sites consume the window. Validation gets whatever time is left.

RFIThe gate
Qualify the CRO
Search previous answers
Chase SMEs
Reconcile responses
Polish and format
Answered from your record
Only gaps routed to SMEs
Commercially polished
→Qualified to bid
Yendou RFI
RFPTen working days
Build a project delivery strategy
01 DevelopCountry & site intelligence
How we believe it should run
02 ValidatePre award feasibility
What the evidence says Whatever can still be checked
03 AssembleProposal
Whatever came backPackage
The window
OUTDay ten
What the sponsor receives

Proposal

  • Project delivery strategy
  • Delivery plan
  • Budget
  • Evidence based validation
  • Project delivery strategy
  • Validated assumptions
  • Validated delivery plan
  • Validated budget
SubmittedReady for bid defence →
Award

The strategy gets written. It rarely gets tested.

Ten days disappear into gathering, chasing, and assembling.

Develop the strategy. Validate it. Then make the proposal.

The same ten days, spent on the argument instead of the chase.

Compounding intelligence

Experience should be an unfair advantage.

Every study your CRO pursues and delivers creates intelligence competitors do not have. Yendou captures it, connects it, and puts it to work on every opportunity that follows.

STUDY 01STUDY 01STUDY 01STUDY 03STUDY 02STUDY 01STUDY 03STUDY 02STUDY 01STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 03STUDY 02STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 06STUDY 05STUDY 04STUDY 08STUDY 07STUDY 09STUDY 08STUDY 07STUDY 09STUDY 08STUDY 07STUDY 09STUDY 09STUDY 09RFI & proposal contentDelivery strategyCountry & site strategyRecruitment benchmarksSite performanceStudy 01Study 02Study 03Study 04Study 05Study 06Study 07Study 08Study 09
One intelligence layer

Turn ten days of RFP coordination
into ten days of competitive strategy.

Yendou handles the retrieval, coordination, and follow-up behind the bid, so your team can focus on the strategy that wins it.

01 · Yendou RFI Qualify more opportunities. Turn previous answers, company knowledge, operational evidence, and SME expertise into stronger sponsor responses without adding work to the proposal team.

Meridian_Torsana_RFI_Response

Torsana · Gastroenterology · Phase 1 · due Aug 20

 Reading your RFI... 12 questions 4 drafted 5 have gaps 3 need you Phase 1 gastroenterology studies delivered in the last five years Clinical OperationsDraft ready Phase 1 gastroenterology programmes since 2019, across Belgium and the Netherlands: study count studies, patients screened, median screen failure rate. Drawn from 3 past proposals and your Phase 1 unit SOPs PV Pieter van LoonClinical Operations Outlook Teams Draft attached Export in sponsor format S6_Torsana_RFP_selection_criteria_TOR-501-101.xlsx B12 Missing: study count Type the missing detailFill PV Ask Pieter van LoonSends just this gap, with the drafted answer attached 02 · Yendou Country & Site Strategy Build a strategy you can defend. Turn protocol requirements, historical performance, and current market intelligence into evidence-backed country and site decisions. Phase 1, gastroenterology Unsaved Drop the protocol synopsis PDF or DOCX Protocol_TOR-501-101_v3.pdf2.4 MB 1. Synopsis 2. Statistical analysis plan Protocol_TOR-501-101_v3.pdfsynopsis & statistical analysis plan Uploading 0% Counting matches... Start from a preset Investigator strength PI publications0.15 PI citations0.25 Delivery evidence Promised against delivered0.30 Zero enrolling site share0.22 Observed recruitment rate0.08 11,221 clinical trials match

4,049 organizations match · showing top 500

Phase 1 gastroenterology · 9 countries · interventional

 Reading the delivery ledger... 62 shortlisted 19 under-delivered 7 with no enrolment record Waalstad Medisch Centrum Utrecht, NetherlandsAcademicNo communication on record Comparable trialPromisedDelivered Phase 2 IBD, 20242411Short by 13 Phase 1 GI, 20231814Short by 4 Phase 2 Crohn's, 202230--Not recorded Startup observed 118 days against a 90 day plan · evidence base 3 trials, one incomplete Held back No enrolment recorded against a 30 patient commitment Reserve rank 4 2 selected Add to list Enrol in workflow Clear Choose a workflow CDA signature Blinded feasibility 03 · Yendou Feasibility Validate before you promise. Validate site interest, recruitment, startup, and delivery assumptions with an email-first experience that needs no site login. ← Back Pre-award Feasibility Feasibility survey SECTION 1 / 4 Drop the sponsor feasibility document 0 questions extractedreading the document Section 1 // Engagement and capacity4 sections 43 questions · 4 sectionsready to send Sponsor_Site_Feasibility.docx 1. Engagement and capacity 2. Patient access Step 1: Initial Emailfirst contact with each organization Use template Yendou Library Feasibility (Potential Investigators) [Initial Email]Feasibility questionnaire - {{study_title}} Feasibility (Potential Investigators) [FU1]Following up: feasibility questionnaire FromMara Lindqvist <mara+meridian@yendou.com> Subject Dear Full Name with Title, The purpose of this questionnaire is to assess feasibility for {{study_title}}. • Phase: {{phase}}   • Therapeutic area: {{therapeutic_area}} • Target enrollment: {{patient_number}} patients   • Sites: {{num_sites}} → Click here to complete the questionnaire: Engagement Request link Activate feasibility outreach Reporting Activities 48 Output 32 Dashboard RecipientProgressOrganization Task progress 24 Jul 2026Task started 5:54 PM, a few seconds later1 question prefilled 6:09 PM, 15 minutes laterLast answer updated 17 of 18 required answered Recipient How would you recruit the adult and adolescent patients? Pts Diff. My Pre-award Feasibility view9 charts · 4 KPIs Total submissions32 Total active patient database413 Average CRC workload15.20 Average active database82.60 Reported patient access by site Nordbach150 Silverlund100 Trevaldi58 CRC workload and availability Nordbach25 Silverlund20 Trevaldi12 Priority assigned to this protocol Top 10 priority 40% Top 3 priority 40% Lower priority 20% Primary constraints to performance PI bandwidth2 Patient access1 Drug logistics1 2 selected Export Uplift site responses to Site CRM Clear 04 · Yendou Proposals Get to bid defence stronger and faster. Carry the strategy, evidence, and validation you already built into the proposal without rebuilding the argument from scratch.In build with a design partner. First release Q4 2026. HELIOS-2, Phase III solid tumour Draft RFP_Aventra_HELIOS-2.pdfrequest for proposal, 41 pages Reading 0% Study profile0 of 11 fields Six fields came from the RFP. Two from your bid team. Three your CRO already knew. BudgetPriced against every oncology study you have run €0Total Margin 32% Win probability 74% Assembled in 40 minutes Clinical monitoring is priced at complexity Level 4. Your own delivery record says Level 5. Comparable studies you have deliveredPlannedActual Solid tumour, Phase III, 12 countriesLevel 4Level 5 Solid tumour, Phase III, 9 countriesLevel 4Level 5 Solid tumour, Phase III, 14 countriesLevel 5Level 5 Six more since 2023, same indicationLevel 45 of 6 Level 5 8 of 10 comparable studies. Adds €267,764. Take Level 5 Priced at Level 4, this study delivers at 30% margin, not 32. The difference shows up eleven months from now. Aventra opened the proposalproposals.yendou.com/helios-2 4 viewers, 47 minutes Where they spent the time Clinical monitoring12 min Medical and safety9 min Biostatistics7 min They pushed on scope and on price, and they kept pharmacovigilance. You know that before the defence, not during it. 05 · Yendou Intelligence Never start the next opportunity from zero. Every answer, site signal, delivery decision, and outcome becomes intelligence for the next bid. PENNANT-4, Phase II gastroenterology New RFP_Quantia_PENNANT-4.pdf9 countries · 34 sites · 180 patients What the record already holdsCarried forward 13 answers need a person 12 sites are new to you Everything else is already yours
Customer outcomes
“We constantly talk about agility and flexibility as differentiators, but are aware that all of our competitors say those things too. We picked Yendou to be able to show proof more easily. That’s what will be more meaningful to a customer. With Yendou, it’s no longer just words.”
VP Business Development Mid-size CRO · 3,500 FTE · US, EU, APAC
“My team moved from chasing functions for RFI answers and sites for feasibility and signatures to building strategy, producing evidence, and strengthening relationships.”
Chief Commercial Officer Mid-cap CRO · After 90 days with Yendou
“We take in five RFPs per week, and it’s never seamless. In a big company, people have lots of competing demands, so it always becomes a last-minute exercise. It’s just horrible. With Yendou, the timeline alone is saving me about half an hour per RFI, and another half-hour to an hour per department head. It’s better. It’s more efficient.”
Head of Global Proposals and Feasibility Global full-service CRO · US, EU, APAC

Every month, Yendou supports 50 RFIs, 800 country and site selection decisions, and 30,000+ SME-site transactions.

Customer outcomes
Enterprise ready

Built for the infrastructure you already have.

Yendou works with your existing systems of record and meets the security requirements of regulated clinical research. No rip-and-replace. Your data is never used to train AI models.

Works with your stack
Keep the systems your teams already rely on.
Signature
Systems of record
Workplace
See integrations →
Built for regulated research
Enterprise security and compliance without compromising how your teams work.
Regulatory
Controls
Compliance
Security documentation →
Your next bid

Make the next study you bid for
the one you win.

See how Yendou turns your CRO’s existing knowledge, expert capacity, and delivery experience into a stronger competitive strategy.

Book an RFP walkthrough